HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.34 CNY | +0.96% |
|
+1.93% | -18.93% |
| Sales 2022 | 9.64B 1.33B | Sales 2023 | 10.39B 1.43B | Capitalization | 4.53B 626M |
|---|---|---|---|---|---|
| Net income 2022 | 263M 36.3M | Net income 2023 | 292M 40.3M | EV / Sales 2022 | 0.39 x |
| Net Debt 2022 | 86.9M 11.99M | Net cash position 2023 | 295M 40.74M | EV / Sales 2023 | 0.41 x |
| P/E ratio 2022 |
14
x | P/E ratio 2023 |
15.5
x | Employees | 2,960 |
| Yield 2022 * |
-
| Yield 2023 |
1.84% | Free-Float | 24.52% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.96% | ||
| 1 week | +1.93% | ||
| Current month | -4.08% | ||
| 1 month | -6.63% | ||
| 3 months | -9.82% | ||
| 6 months | -12.91% | ||
| Current year | -18.93% |
1 week
6.09
6.39
1 month
5.786.80
Current year
4.968.45
1 year
4.9610.50
3 years
4.9610.50
5 years
4.9611.50
10 years
4.8829.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 55 | - |
Ping Guan
DFI | Director of Finance/CFO | 52 | 22-04-06 |
Yu Hong Bao
ADM | Chief Administrative Officer | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Dong Meng
CHM | Chairman | 52 | - |
Bo Liu
BRD | Director/Board Member | 61 | - |
Wei Dong Zhu
CEO | Chief Executive Officer | 55 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 6.34 | +0.96% | 4,236,400 |
| 24-04-23 | 6.28 | +0.96% | 5,371,578 |
| 24-04-22 | 6.22 | +0.16% | 5,771,800 |
| 24-04-19 | 6.21 | +0.49% | 3,939,339 |
| 24-04-18 | 6.18 | -0.64% | 5,421,600 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is a China-based company, principally engaged in the wholesale and retail of pharmaceuticals. The Company principally engages in the sales of Chinese medicines and western drugs. It also engages in the sales of medical equipment, healthcare products, daily necessities, glass apparatus, chemical, among others. The Company distributes its products mainly within domestic markets.
Sector
Pharmaceuticals
Calendar
2024-08-18
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -18.93% | 503M | |
| +15.65% | 69.91B | |
| +2.72% | 25.14B | |
| +5.62% | 8.32B | |
| +6.10% | 8.07B | |
| -21.85% | 7.97B | |
| +0.73% | 4.56B | |
| +17.40% | 4.31B | |
| -0.14% | 3.99B | |
| -2.34% | 3.87B |
- Stock Market
- Equities
- 600829 Stock
